• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型正性肌力药物对收缩蛋白钙敏感性的影响。

Effects of new inotropic agents on Ca++ sensitivity of contractile proteins.

作者信息

Rüegg J C

出版信息

Circulation. 1986 Mar;73(3 Pt 2):III78-84.

PMID:2935329
Abstract

In cardiac muscle the relationship between contraction and the intracellular free calcium concentration is not unique but may vary over a wide range, as when influenced by new positive inotropic drugs. Modulation of the sensitivity of myofilaments to calcium may be studied in chemically skinned fibers devoid of a functional sarcoplasmic reticulum and in which the ionic composition of the interfilament space can be controlled and influenced at will. At low levels of activation with Ca++ (1 microM), the new nonglycosidic, nonadrenergic cardiotonic drugs sulmazole (AR-L 115 BS) and pimobendane (UD-CG 115 BS) increase calcium-induced contraction of skinned mammalian cardiac fibers by 30% to 50% in concentrations at which they exert a positive inotropic effect in vivo. The effect on skinned fibers is due to an increase in the sensitivity of the myofilaments to calcium and, at least in the case of sulmazole, may be attributed to an increase in calcium affinity of troponin. Calcium-induced contraction of skinned fibers from vertebrate smooth muscle that lacks troponin is not activated by sulmazole and pimobendane. Thus the positive inotropic action of these new cardiotonic drugs might be accounted for in part by their calcium-sensitizing action of myofilaments, although other mechanisms that increase intracellular free calcium may be involved as well.

摘要

在心肌中,收缩与细胞内游离钙浓度之间的关系并非单一,而是可能在很宽的范围内变化,如新的正性肌力药物影响时。肌丝对钙的敏感性调节可在去除功能性肌浆网的化学去表皮纤维中进行研究,在这种纤维中,肌丝间空间的离子组成可随意控制和影响。在低水平Ca++(1微摩尔)激活时,新型非糖苷、非肾上腺素能强心药物舒马唑(AR-L 115 BS)和匹莫苯丹(UD-CG 115 BS)在体内发挥正性肌力作用的浓度下,可使去表皮哺乳动物心脏纤维的钙诱导收缩增加30%至50%。对去表皮纤维的作用是由于肌丝对钙的敏感性增加,至少就舒马唑而言,可能归因于肌钙蛋白对钙的亲和力增加。舒马唑和匹莫苯丹不会激活缺乏肌钙蛋白的脊椎动物平滑肌去表皮纤维的钙诱导收缩。因此,这些新型强心药物的正性肌力作用可能部分归因于它们对肌丝的钙敏化作用,尽管也可能涉及其他增加细胞内游离钙的机制。

相似文献

1
Effects of new inotropic agents on Ca++ sensitivity of contractile proteins.新型正性肌力药物对收缩蛋白钙敏感性的影响。
Circulation. 1986 Mar;73(3 Pt 2):III78-84.
2
Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.新型强心剂MCI - 154对豚鼠乳头肌化学去膜纤维收缩系统Ca++敏感性的增强作用。
J Pharmacol Exp Ther. 1987 Nov;243(2):633-8.
3
Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.新型强心剂MCI-154通过直接增强肌钙蛋白C与钙离子的结合,有力地刺激犬心肌的肌丝力和三磷酸腺苷酶活性。
J Pharmacol Exp Ther. 1989 Jul;250(1):272-7.
4
The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments.匹莫苯丹的正性肌力作用涉及心肌肌丝钙敏感性的立体特异性增加。
J Cardiovasc Pharmacol. 1989;14 Suppl 2:S7-12.
5
Phosphodiesterase-inhibiting properties of newer inotropic agents.新型正性肌力药物的磷酸二酯酶抑制特性。
Circulation. 1986 Mar;73(3 Pt 2):III99-108.
6
Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.正性肌力药物匹莫苯丹和舒马唑在体内的心血管效应。
Arzneimittelforschung. 1985;35(1A):284-8.
7
Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone.一种新型苯并咪唑衍生物4,5-二氢-6-[2-(4-甲氧基苯基)-1H-苯并咪唑-5-基]-5-甲基-3(2H)-哒嗪酮对哺乳动物心脏和平滑肌去表皮纤维收缩性的影响
Arzneimittelforschung. 1984;34(12):1736-8.
8
MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.新型强心剂MCI - 154可逆转酸性pH值引起的心肌肌丝对钙离子反应性的降低:与舒马唑和匹莫苯丹的比较。
J Pharmacol Exp Ther. 1991 May;257(2):812-9.
9
Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.犬和豚鼠心脏肌丝对Ca2+激活的敏感性及匹莫苯丹的正性肌力作用:与米力农的比较。
Circ Res. 1988 Nov;63(5):911-22. doi: 10.1161/01.res.63.5.911.
10
Modification of myofibrillar responsiveness to Ca++ as an inotropic mechanism.
Circulation. 1986 Mar;73(3 Pt 2):III85-98.

引用本文的文献

1
E-1020, a water soluble imidazopyridine, has direct effects on Ca(2+)-dependent force and ATP hydrolysis of canine and bovine cardiac myofilaments.E-1020是一种水溶性咪唑并吡啶,对犬和牛心肌肌丝的钙依赖力和ATP水解有直接影响。
Mol Cell Biochem. 1996 Jul-Aug;160-161:33-9. doi: 10.1007/BF00240028.
2
Clinical effects of long-term administration of pimobendan in patients with moderate congestive heart failure.长期给予匹莫苯丹对中度充血性心力衰竭患者的临床疗效。
Heart Vessels. 1994;9(3):113-20. doi: 10.1007/BF01745236.
3
Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.
匹莫苯丹。其在充血性心力衰竭中的药理学及治疗潜力综述。
Drugs Aging. 1994 May;4(5):417-41. doi: 10.2165/00002512-199404050-00007.
4
Plasma and red blood cell pharmacokinetics of pimobendan enantiomers in healthy Chinese.匹莫苯丹对映体在健康中国人群中的血浆和红细胞药代动力学
Eur J Clin Pharmacol. 1995;47(6):537-42. doi: 10.1007/BF00193708.
5
Improved ventricular function by enhancing the Ca++ sensitivity in normal and stunned myocardium of isolated rabbit hearts.通过增强离体兔心脏正常和顿抑心肌中的钙离子敏感性来改善心室功能。
Basic Res Cardiol. 1994 Nov-Dec;89(6):549-62. doi: 10.1007/BF00794955.
6
Low concentrations of UD-CG 212 enhance myocyte contractility by an increase in calcium responsiveness in the presence of inorganic phosphate.低浓度的UD-CG 212在无机磷酸盐存在的情况下,通过提高钙反应性来增强心肌细胞收缩力。
Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):644-50. doi: 10.1007/BF00170165.
7
[Calcium regulation of muscle contraction: the molecular regulation mechanisms of contracility].
Naturwissenschaften. 1987 Dec;74(12):579-84. doi: 10.1007/BF00368515.
8
Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses.匹莫苯丹(UD-CG 115 BS)治疗重度充血性心力衰竭。两种不同剂量的急性血流动力学交叉双盲研究。
Br J Clin Pharmacol. 1988 Mar;25(3):323-9. doi: 10.1111/j.1365-2125.1988.tb03310.x.
9
Recruitment of inotropic reserve in "stunned" myocardium by the cardiotonic agent AR-L 57.强心剂AR-L 57对“顿抑”心肌收缩储备的募集作用
Basic Res Cardiol. 1988 Nov-Dec;83(6):602-10. doi: 10.1007/BF01906954.
10
Cyclic AMP-dependent and cyclic AMP-independent actions of a novel cardiotonic agent, OPC-8212.新型强心剂OPC-8212的环磷酸腺苷依赖性和非环磷酸腺苷依赖性作用
Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):692-8. doi: 10.1007/BF00165636.